There are few reliable experimental systems available to study the molecular mechanisms that govern human embryonic development. Embryonal carcinoma (EC) cells are pluripotent stem cells derived from teratocarcinomas and are considered the malignant counterparts of human embryonic stem (ES) cells. Several of the existing human EC stem cell lines provide robust and simple culture systems to study certain aspects of cellular differentiation in a manner pertinent to human embryogenesis. Here we review the strategies used to derive and characterize the established and recognized human EC stem cell line TERA2.cl.SP12. Furthermore, we demonstrate the value of human EC stem cells as a model of early development and focus on cell fate determination in the embryonic ectoderm.
INTRODUCTION P
LURIPOTENT STEM CELLS of the blastocyst inner cell mass have the ability to differentiate into multiple lineages that ultimately give rise to the embryo proper. Cultures of pluripotent embryonic stem (ES) cells derived from the blastocyst self-renew in vitro and maintain their ability to differentiate. Accordingly, stem cells of this type provide a unique opportunity for studying the fundamental mechanisms and control processes that function to determine the fate of cells during early embryonic development (for review, see ref. 1) . Pluripotent stem cells have attracted the attention of scientists not only as tools for basic research but also as a renewable source of material for potential therapeutic applications. Indeed, the use of stem cells for medical purposes has been especially promoted since the isolation of human ES cells in 1998 (2) . However, much of what we currently know about pluripotent stem cells is based on decades of earlier research on murine ES cells and embryonal carcinoma (EC) stem cells.
Pluripotent EC cells are derived from tumors known as teratocarcinomas that are understood to arise from transformed germ cells. EC cells are the stem cells of such tumors and are generally considered to be the malignant counterparts of ES cells (for review see ref.
3). For many years, EC cells have served as convenient tools for investigation of the molecular mechanisms by which stem cells select alternative pathways of differentiation during embryonic development. Seminal work with murine and human EC cells led to the development of technologies resulting in the derivation of totipotent diploid ES cells from mouse blastocysts (4, 5) , which in turn ultimately led to the isolation of human ES cells from blastocysts (2) .
Although we are now beginning to appreciate fully the potential of ES cell technology, we must also recognize that many technical challenges lie ahead. For example, the culture of several of the existing human ES cell lines is reliant on their growth and maintenance on embryonic fibroblast feeder cells (2, 6, 7) . This poses practical difficulties for their routine use and for when it is necessary to expand cultures and produce larger amounts of cell material. Furthermore, it is well known that suboptimal culture conditions can lead to spontaneous differentiation of human ES cells, introducing contaminating cell types. The propensity of ES cells to differentiate and produce all somatic cell types is their primary feature as a valued re-source and experimental tool. However, we currently know relatively little about how to control and manipulate ES cell differentiation to produce exclusive populations of specific tissue types. Although these problems are recognized and ongoing work continues to address these issues, research using human EC cells as models of early embryogenesis remains a useful, viable alternative. In contrast to human ES cells, the capacity of EC stem cell differentiation is limited and this can sometimes be put to advantage because EC stem cells provide a simpler and more robust experimental system. In this report, we examine some of the characteristics and attributes of human EC cells and present evidence of their potential as a model for cell fate determination in the embryonic ectoderm.
DERIVATION OF HUMAN EMBRYONAL CARCINOMA STEM CELL LINES
For many years, teratocarcinomas and their stem cells, EC cells, have been used as established models for investigating cell differentiation, especially in the mouse (8) . More recently, lines of human EC cells have been characterized to extend this approach to human embryogenesis (9,10). There is considerable variation between a number of the human EC stem cell lines currently in existence such that different lineages will have alternate advantages and disadvantages for use in research. This is often reflected in the manner by which human EC lines were originally derived, by the way that they are subsequently maintained, and by their capacity for differentiation. For example, several clonal cell lines isolated from the human teratoma lineage GCT27 may be termed as either multipotent and give rise to multiple differentiated derivatives or nullipotent with no evidence of differentiation (10) . Multipotent cells derived from GCT27 require feeder cell support for proliferation and are capable of forming cell types representative of all three germ layers. In contrast, human NTERA2.cl.D1 EC cells grow independently of feeder cell layers (9) , but may have a more restricted capacity for differentiation (11) . Such differences are not easy to explain, especially given the aneuploid nature of EC stem cells, the fact that EC stem cells are derived from different sources using different techniques, and that some clonal lineages derived from a single parent line also appear to have varying abilities for differentiation (10, 12, 13) . As a consequence, it is likely that the isolation of further EC clonal lineages may produce additional cell lines showing further variation in their ability to differentiate and having useful characteristics appropriate for the study of particular pathways of human development.
To explore this possibility, we developed a strategy using a combination of immunomagnetic isolation and single-cell selection to derive new clonal lineages of human pluripotent stem cells (14) . This direct approach allows the isolation of pluripotent cells from heterogeneous samples, whether they are embryonic tissues, surgically isolated tumor materials, or cultures of explanted cells. Human pluripotent stem cells are readily identified by their expression of specific cell-surface antigens, for example, stage-specific embryonic antigen 4 (SSEA-4). Figure 1 shows cultures of the explanted germ cell tumor line TERA2 that contain approximately 2-3% EC stem cells, which can be readily isolated using SSEA-4 immunoreactive magnetic particles. Seeding individual EC cells into multiwelled plates and culturing them for extended periods, enables the creation of multiple clonal lin-PRZYBORSKI ET AL. Of all the cell lines produced using this approach, human TERA2.cl.SP12 EC stem cells appeared the most robust and displayed characteristics most similar to other human pluripotent stem lineages (14) .
However, differences do exist between related cell lines. For example, TERA2.cl.SP12 cells were derived directly from the earliest available passage of the parent explant culture TERA2 (14), whereas NTERA2.cl.D1 was originally derived from a xenograft tumor of the parent TERA2 line (9) . Furthermore, initial experiments examining their capacity for differentiation showed that TERA2.cl.SP12 cells appeared to have a greater propensity for neural development than NTERA2.cl.D1 cells (14) .
Accordingly, TERA2-derived lineages are particularly useful as experimental tools to investigate the molecular mechanisms that control the differentiation of human neural tissues. It is currently not known why differences exist between different clonal lines of closely related pluripotent stem cells, but it may be a consequence of their genetic instability or the methods by which they were derived.
CHARACTERIZATION OF HUMAN EC STEM CELL LINES
A primary characteristic of pluripotent stem cells is their ability to differentiate. Kliensmith and Pierce (15) provided the first evidence that EC cells are the malignant stem cells in germ cell tumors that give rise to the differentiated tissues within teratocarcinomas. Transplantation of a single EC cell into an appropriate host was sufficient to result in the formation of a new teratocarcinoma consisting of differentiated cells of multiple types (15) . Similarly, when TERA2.cl.SP12 EC stem cells were grafted subcutaneously into severe combined immunodeficient (SCID) mice, they produced complex xenograft tumours containing many cell types, including a high proportion of neural and epithelial derivatives (Fig. 2) .
Many, but not all, human EC stem cell lines also retain the capacity to differentiate in vitro (10, (12) (13) (14) . TERA2.cl.SP12 stem cells respond to exogenous compounds such as retinoic acid and produce highly heterogeneous cultures of differentiating cells, whereas exposure to hexamethylene bisacetamide (HMBA) results in more homogeneous development (Fig. 3) . However, the addition of exogenous stimuli is not always required to induce pluripotent stem cells to form other cell types. It is well known that cultured human ES and EC stem cells can spontaneously differentiate when grown in subopti- mal conditions. For example, human ES cells rely on embryonic fibroblast feeders to maintain their undifferentiated phenotype (2), whereas cell density and the confluency of a culture can influence the differentiation of rameter is straightforward to control, and homogeneous cultures of undifferentiated TERA2.cl.SP12 EC stem cells are easily achieved on a routine basis allowing users to culture large numbers of stem cells in a consistent manner.
Several markers are available that are characteristic of human pluripotent stem cells and prove to be useful tools to monitor their undifferentiated phenotype. For example, octamer-binding transcription factor-4 is encoded by the pou5F1 gene and is expressed highly in human ES and EC stem cells but not in their differentiated derivatives (1, 14) . Routine assessment of growing cultures of pluripotent stem cells can be readily achieved using immunofluorescence and flow cytometry to detect the expression of cell-surface antigens specific to human ES and EC stem cells, notably SSEA3, SSEA4, and TRA-1-60 (14, 18, 19) . SSEA3, SSEA4, and TRA-1-60 are strongly expressed in cultures of TERA2.cl.SP12 cells, whereas decreased levels of these markers can be indicative of cellular differentiation (Fig. 4) .
DIFFERENTIATION OF HUMAN EC STEM CELLS IN VITRO
Differentiation by human EC stem cell lines is variable. As mentioned above, this can amount to subtle differences between related sublineages or significantly different development potentials between unrelated cell lines. Many human EC lines are unable to differentiate and produce morphologically identifiable cell types, but a number of lineages that do differentiate extensively have been described. The EC cell line GCT27 is maintained on feeder layers to prevent spontaneous differentiation (10) . However, when the feeder cells are removed, PRZYBORSKI ET AL. human EC stem cells (16, 17) . Spontaneous differentiation is minimal in cultures of human TERA2.cl.SP12 EC stem cells, providing that they are grown and maintained at high confluency (Fig. 1) . In a practical sense, this pa-GCT27 cells differentiate into various tissues, including cells with neural properties. Alternatively, GCT27 cells also have the ability to form extraembryonic endoderm when exposed to retinoic acid (20) and differentiate in response to bone morphogenetic protein-2 (21). Several other human EC stem cell lines also exist that possess the ability to differentiate extensively, notably NCCIT (22) and NCR-G3 (23), but perhaps the most comprehensively studied are those lineages derived from the EC stem cell line TERA2. The TERA2 line was originally derived from a metastasis of a testicular teratocarcinoma (24) . TERA2 and its various sublineages, most notably NTERA2.cl.D1 and TERA2.cl.SP12, form well-differentiated teratomas when grown as xenografts in immunodeficient mice (Fig. 2) and differentiate in response to retinoic acid and other agents in vitro (Fig. 3) (3) . During induction of differentiation, TERA2-derived cells rapidly lose their EC stem cell phenotype and acquire different growth characteristics and altered morphologies. Cultures of EC stem cells exposed to retinoic acid or HMBA typically lose their expression of cell-surface antigens specific for pluripotent human stem cells (e.g., SSEA3, SSEA4, TRA-1-60) whereas simultaneously acquiring a variety of other antigens that commonly appear on the surface of differentiated cells (25) . Specifically, TERA2-derived cells exposed to retinoic acid show increased expression of antigens immunoreactive to antibodies associated with neuroectodermal derivatives such as A2B5 and VINIS-56 (12, 14, (26) (27) (28) (Fig. 4) . In contrast, expression levels for both these markers are significantly lower in HMBA-induced cultures, which are generally devoid of neurons (Fig. 4) . Consistent with this observation is the lack of markers for maturing neurons, such as neurofilaments, in cultures exposed to HMBA (Fig. 5) . Furthermore, HMBA-induced cells up-regulate molecules associated with the formation of epithelial derivatives, suggesting that cells commit primarily toward epidermal ectoderm as apposed to neural ectoderm (Fig. 5 , Table  1 ). Cultures exposed to retinoic acid, however, are heterogeneous and consist of both neural and nonneural components (nonneural cells having been identified as being primarily epithelial in nature by immunocytochemical staining, unpublished data). These initial results indicate that TERA2.cl.SP12 EC cells have the capacity to form different cell types in vitro and that the pluripotent EC stem cell system may prove useful to study cell fate determination in the human embryonic ectoderm.
The differentiation of cultured NTERA2.cl.D1 and TERA2.cl.SP12 EC stem cells into neurons follows a similar pathway to that observed by neural ectodermal precursors during vertebrate neurogenesis in vivo (3, (27) (28) (29) . Notably, the expression of nestin, a gene that encodes an intermediate filament protein typically found in neuroprogenitor cells, is markedly up-regulated shortly after TERA2-derived cells are exposed to retinoic acid. This transient peak in nestin expression is immediately replaced by an up-regulation in neuroD1, a proneural transcription factor gene of the basic helix-loop-helix family that is characteristic of postmitotic neuroblasts of the embryonic nervous system. Subsequently, molecules typical of maturing neurons become expressed, for example, neurofilaments and synaptophysin. Furthermore, transcriptional profiling has identified that the expression of Pax6 and Nkx6.1, and the almost complete absence of dorsal markers such as Pax7 suggests that neurons generated from human pluripotent EC stem cells are ventral in character (29) . Functional characterization of mature neural cells produced from TERA2-derived cultures has shown that such neurons possess tetrodotoxin-sensitive sodium channels (30) , functional synapses (31), and a variety of other neurophysiological features, including the presence of calcium receptors and sensitivity to glutamate, ␥-aminobutyric acid (GABA), and glycine (32, 33 , and unpublished data). Terminally differentiated functional neurons are a valuable resource for screening drugs, testing the toxicity of new compounds, and as a potential source of transplantable material to correct neurological deficits. Indeed, experiments in rodents have shown that TERA2-derived cells survive and integrate functionally to correct behavioral defects resulting from experimentally induced cerebral ischemia and injury to the brain (34) (35) (36) . 2-7) . Cells were induced to differentiate by the exogenous application of 10 M retinoic acid (lanes 2-4) or 3 mM HMBA (lanes 5-7) for 7, 14, and 28 days (lanes 2-4 and 5-7, respectively). Cells were grown, sampled, and analyzed as previously reported (28) . Expression of ␤-actin was used as a loading control. Neural markers showed strong expression in samples of retinoic acid-induced cells, whereas neurofilament expression was not detected in samples of HMBA-induced cultures indicating the absence of maturing neurons. Alternatively, elevated levels of cytokeratin 8 by HMBA-induced cells indicated greater amounts of epithelial differentiation compared to retinoic acid-induced cultures.
Studies on neural development by human EC cells have focused primarily on the NTERA2.cl.D1 lineage (3, 27, 29, 37) and, more recently, on TERA2.cl.SP12 cells (14, 28, 38) using previously defined methods to induce the neuronal phenotype (37, 39) . In brief, these techniques involve the growth of human EC cells as confluent monolayers of adherent cells on tissue culture plastic during exposure to retinoic acid for at least 3-4 weeks to induce the differentiation of identifiable neurons (Fig. 3) . In this way, 10-20% of retinoic acid-induced TERA2.cl.SP12 cells typically form neurons that can be isolated and purified from cells that appear nonneuronal in nature (28) (Fig. 6) . The production of neurons by this method is clearly inefficient because most TERA2.cl.SP12 cells form nonneural derivatives. As suggested earlier, TERA2.cl.SP12 cells appear to make a decision as to whether to commit to a neural or epidermal fate subsequent to exposure to retinoic acid. An important question, therefore, is what molecular mechanism controls this decision process?
Experiments in vertebrates, particularly Xenopus laevis, have begun to unravel the molecular basis of important cell fate decisions during the formation of neural and epidermal progenitor cells from the embryonic ectoderm. It was Speman and Mangold (40) who first showed that amphibian embryonic ectoderm could be induced to form neural tissue and that such effects were orchestrated by signals produced by cells in the dorsal lip region (later termed the Speman Organizer). Other experiments showed that when ectodermal explants were dissociated for an extended period of time and cultured alone in Ca 2ϩ -and Mg 2ϩ -free buffer, the cells changed their fates from epidermal to neural (41) (42) (43) . From these experiments it was concluded that inhibitory factors might exist in intact ectodermal explants that were lost during cell dissociation.
Using a cell dissociation assay, Wilson and HemmatiBrivanlou (44) first identified that bone morphogenetic protein-4 (BMP4) a member of the transforming growth factor-␤ (TGF-␤) superfamily, was able to suppress the expression of neural markers and induce epidermal keratin expression. Other BMPs are also reported to be neural inhibitors and epidermal inducers (45) . These experiments indicate that endogenous BMPs may be responsible for maintaining the specification of epidermal progenitors in intact tissues. Consistent with this notion are experiments that block BMP activity resulting in neural development (46, 47) .
It is known from earlier work that BMP signaling is active and plays an important role in specifying the type of differentiation arising from TERA2-derived EC stem cells (48, 49) . Furthermore, we have provided evidence that BMPs are significantly up-regulated in cultures of EC cells exposed to HMBA, and this correlates with their expression of epithelial markers (Table 1) . Taking into account the earlier cell-dissociation experiments (41) (42) (43) and other studies with murine ES cells (50), we have developed methods to manipulate the ectodermal fate of differentiating human EC cells. Such changes in growth conditions increase the efficiency of neuron production from cultures of human EC stem cells (38) . We have found that if TERA2.cl.SP12 EC stem cells are maintained in sterile bacteriological dishes as dissociated single-cell suspensions for 1-2 days prior to exposure to retinoic PRZYBORSKI ET AL. acid for a further 14 days in suspension, the cells form spherical aggregations, which produce large numbers of neurites when subsequently adhered and grown on poly-D-lysine and laminin-coated glass (Fig. 6) . Immunocytochemical staining of these neural structures demonstrated that Ͼ95% of the cells in the aggregates were neural in character. We have also developed growth conditions that can also result in the production of glial cell types (28), and we have devised efficient strategies to dissociate aggregates of neural cells (Fig. 6) .
Accordingly, through relatively simple manipulation of the culture environment, we can control the commitment of human EC stem cells toward a distinct neural pathway of differentiation. It is possible that this effect could simply be due to the lack of nonneural cells in suspended cultures. However, we believe that this is unlikely because more cells commit to the neuronal pathway at the beginning of differentiation-there was a 5-to 10-fold increase in the numbers of neurons produced compared to adherent cultures (28) . Given the similarities between our observations and the cell-dissociation experiments in Xenopus (41-44), we hypothesize that signaling events involving members of the TGF-␤ superfamily occur between differentiating human EC cells and that such signaling is disrupted during prolonged cell dissociation and consequently influences the induction of neural differentiation. In support of this notion, additional preliminary experiments have shown the suppression of epithelial marker expression in cultures that have undergone cell dissociation and growth in suspension whereas markers of neural differentation increased (Fig. 7) . Moreover, the addition of exogenous BMP2 has been shown to knock down the expression of neural markers by TERA2.cl.SP12 cells grown as aggregates and promote the up-regulation of proteins commonly expressed by epithelial cells (data not shown). Previously, we have reported how microarray analysis using Affymetrix Gene Chip ® technology can be used to compare samples of RNA from human EC cells (29) . The data in Table 1 show the difference in expression of various genes when purified samples TERA2-derived neurons and HMBA-induced cells were compared directly using similar a microarray approach. In general, neural markers are strongly expressed in samples of purified neurons, whereas molecules associated with the formation of the epidermal ectoderm are up-regulated in cells exposed to HMBA.
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FIG. 7.
Differential regulation of neural and epithelial markers during alternative modes of differentiation by human EC stem cells. Western analysis of protein expression for neural markers, neuron-specific enolase (NSE), and the epithelial marker cytokeratin 8 was performed on samples of TERA2. cl.SP12 stem cells (lane 1) and their differentiated derivatives (lane 2-6). As previously reported (38) , cells were induced to differentiate as suspended aggregates in response to 10 M retinoic acid for 4, 7, 11, 18, and 25 days (lanes 2-6, respectively). Expression of ␤-actin was used as a loading control. These data clearly demonstrate that when human TERA2. cl.SP12 EC cells are grown as aggregates, they differentiate and commit toward the neural lineage, while evidence of epidermal differentiation is reduced.
SUMMARY
Many of the fundamental regulatory mechanisms involved in the control of vertebrate development are highly conserved across diverse species; however, differences certainly exist at the cellular and molecular levels. Given that there are practical, ethical, and moral issues concerning work with human embryonic materials, human teratocarcinomas, and their EC stem cells offer an alternative experimental system to study whether pathways determined in lower vertebrates are conserved and functional in human development. The recent characterization of primate ES cells has confirmed that human EC stem cells are closely related to the pluripotent cells of the early embryo. Accordingly, experiments with human EC stem cells will continue to provide important information about the molecular mechanisms that control cell differentiation in humans. Although limited in their ability to differentiate, human EC stem cells do provide an amenable, robust, and more simplistic experimental model. Each system has advantages and disadvantages, but it is likely that cultures of human ES cells and EC stem cells will exist as interdependent tools for experimental research for years to come.
